Navigation Links
Erbitux Plus Chemo Improves Lung Cancer Outcomes
Date:5/31/2008

Survival extended 5 weeks; benefit seen in all subtypes of disease, researchers say

SATURDAY, May 31 (HealthDay News) -- The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy.

Medical professionals have known the drug improved survival, but the question has been by how much.

"This will give us more options to treat patients with non-small cell lung cancer, for whom the prognosis is very poor. Five-year survival is less than 5 percent," said Dr. Shakun Malik, director of the lung cancer program at Georgetown's Lombardi Comprehensive Cancer Center in Washington, D.C.

"We haven't had much happening in the treatment of lung cancer for a long time," she added. "We now have some tremendous progress being made, and most of this is from the addition of biological therapies."

"For lung cancer, a small step forward is a big step, but it's always a question - this is four or five weeks, what does that really mean?" said Dr. Karen Reckamp, an assistant professor of medicine at City of Hope Cancer Center in Duarte, Calif.

There have been other trials involving Erbitux with similar chemotherapy regimens which did not show any benefits. This is the second study that has shown an improvement, Reckamp said.

"We have other negative studies. How is this going to fit into our packet? It does show a survival benefit. The toxicities are probably relatively reasonable," Reckamp said. "I think it's a drug that, with some discussion and some careful understanding of how this trial is different, will be something we do utilize in the right patients."

Avastin (bevacizumab), which blocks blood supply to the tumor, is currently the only targeted therapy approved for this type of lung cancer. Erbitux would be the second such drug approved for this us
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
2. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
3. Avastin Added to Chemo Helps Women With Advanced Cancer
4. Chemo May Limit Fertility in Breast Cancer Survivors
5. OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
6. Study suggests chemotherapy diminishes fertility in breast cancer patients
7. Antioxidant supplements may lessen benefit of radiation and chemotherapy
8. Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer
9. Not All Colon Cancer Patients Need Chemotherapy: Study
10. Chemotherapy might help cancer vaccines work
11. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... As if mood swings, cramps and child labor weren’t enough ... leg pain. Northeast Houston Vein Center is offering tips on the treatment options for ... is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, cramps ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the High-Cost ... was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , The ...
(Date:7/1/2015)... ... July 01, 2015 , ... Boar’s ... helping families get ready for Independence Day celebrations with new takes on classic ... versatile options are perfect for any summertime get together. , “Celebrating with family, ...
(Date:7/1/2015)... ... , ... Author Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But ... support of the practice; a terrible car accident years ago left her injured and in ... Need It ? (And What if I Do?): Answers to All Your Questions about Plastic ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Who doesn’t ... and purpose in life with a healthy balance between work and life, and positive ... in her new book, Positive Health: Flourishing Lives, Wellbeing in Doctors. , With a ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2
... GenVec, Inc. (Nasdaq: GNVC ) announced that it will ... on Thursday, August 6, 2009 after market close. GenVec will hold ... 2009 to discuss the company,s second quarter results. , ... ) , , To listen to the live ...
... ATLANTA, July 30 CryoLife, Inc. (NYSE: ... cardiovascular tissue processing company, announced today that revenues for the ... record of $28.2 million compared to $27.2 million for the ... of $44,000 and $297,000 for the second quarters of 2009 ...
... , NEW YORK, July 30 The growth ... target treatments to patients through the use of information about an ... is expected to increase the number of alliances between diagnostic and ... LLP (PwC) report entitled Diagnostics 2009: Moving towards personalized ...
... , , , ... a leading provider of comprehensive home health services, today reported the following 2009 ... Net revenues of $298.1 million for the quarter ended June 28, ... its CareCentrix business unit, for the quarter ended June 29, 2008. Excluding prior ...
... , , ... Board: NWCI) a cardiac diagnostic and services company, today announced ... suite, NewCardio,s first commercial product, as the technology that will ... (TQT) studies. , , The pharmaceutical ...
... , , ... leading provider of information and business intelligence for students, professionals ... pharmaceutical industry, today launched an enhanced version of AdisOnline ( ... providing a host of user-customizable features and purchasing options that ...
Cached Medicine News:Health News:GenVec Announces Second Quarter 2009 Results Conference Call 2Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 2Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 3Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 4Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 5Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 6Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 7Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 8Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 9Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 10Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 11Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 12Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 13Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 14Health News:CryoLife Reports Record Quarterly Revenues of $28.2 Million 15Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 2Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 3Health News:Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers 4Health News:Gentiva Reports Second Quarter 2009 Results 2Health News:Gentiva Reports Second Quarter 2009 Results 3Health News:Gentiva Reports Second Quarter 2009 Results 4Health News:Gentiva Reports Second Quarter 2009 Results 5Health News:Gentiva Reports Second Quarter 2009 Results 6Health News:Gentiva Reports Second Quarter 2009 Results 7Health News:Gentiva Reports Second Quarter 2009 Results 8Health News:Gentiva Reports Second Quarter 2009 Results 9Health News:Gentiva Reports Second Quarter 2009 Results 10Health News:Gentiva Reports Second Quarter 2009 Results 11Health News:Gentiva Reports Second Quarter 2009 Results 12Health News:Gentiva Reports Second Quarter 2009 Results 13Health News:Gentiva Reports Second Quarter 2009 Results 14Health News:Gentiva Reports Second Quarter 2009 Results 15Health News:Gentiva Reports Second Quarter 2009 Results 16Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 2Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 3
(Date:7/1/2015)... July 1, 2015 Radiant Insights ... Stationary Oxygen Concentrators Market Shares, Strategy, and Forecasts, ... achieve continuing growth as the aging population worldwide needs ... respiratory conditions where oxygen is able to improve the ... devices have become affordable and support a mobile lifestyle ...
(Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... April 12, 2012  Qualitest Pharmaceuticals today announced that the ... Solution, 100mg/mL. Qualitest plans to begin distribution in mid-2012. ... Solution, 100mg/mL, in the U.S. for the 12 months ... to IMS Health. About Qualitest ...
...  Quest Diagnostics Incorporated (NYSE: DGX ) today ... Mohapatra, Ph.D. as President and Chief Executive Officer, effective ... role through April 30 to ensure a smooth leadership ... the Board of Directors.  (Photo: ...
Cached Medicine Technology:Quest Diagnostics Names Steve Rusckowski as President and CEO 2Quest Diagnostics Names Steve Rusckowski as President and CEO 3
... laboratory information system (LIS) with the ... deliver - high ROI, a secure ... LabWeb features advanced functionality like rules-based ... in-depth analysis, and quality assurance and ...
... II is the industrys most powerful ... Offering an impressive range of features ... complex network LIS packages, Beethoven II ... laboratory operations. The system has been ...
Velocity works cooperatively with LabSofts LabNet LIS, allowing the convenience of 24-hour access to information from satellite lab locations, hospitals, physician offices and even homes....
... IntelliLab is a full-featured laboratory ... processing requirements,of clinical laboratories in ... IntelliLab provides order,management, barcode label ... and reporting tools to,ensure that ...
Medicine Products: